Owkin finds new CBO in Sanofi SVP
Plus CEO Séjourné moves to Aurobac and updates from Quantum, BioHaven and more
AI-based medical research company Owkin Inc. hired Alban de La Sablière as CBO. de La Sablière joins from Sanofi (Euronext:SAN; NASDAQ:SNY) where he was SVP global head of partnering, having previously led the French M&A practice at Morgan Stanley.
Antibacterial company Aurobac Therapeutics S.A.S. named Florence Séjourné as CEO. Séjourné was CEO at Da Volterra and co-founder of Genfit S.A. (Euronext:GNFT; NASDAQ:GNFT)...